The New England journal of medicine
-
Comment Letter
Transcatheter Aortic-Valve Replacement in Clinical Practice.
-
Randomized Controlled Trial
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe - Preliminary Report.
The replication-competent recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. ⋯ In these studies, rVSV-ZEBOV was reactogenic but immunogenic after a single dose and warrants further evaluation for safety and efficacy. (Funded by the Wellcome Trust and others; ClinicalTrials.gov numbers, NCT02283099, NCT02287480, and NCT02296983; Pan African Clinical Trials Registry number, PACTR201411000919191.).
-
Letter Comparative Study
Role of Assay Type in Determining Free 25-Hydroxyvitamin D Levels in Diverse Populations.